Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Eledon Pharmaceuticals, Inc. (ELDN) had Return on Equity of -95.81% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-31.63M |
|
-- |
|
-- |
|
$22.87M |
|
$-22.87M |
|
$-8.76M |
|
$-31.63M |
|
$-31.63M |
|
$-31.63M |
|
$-31.63M |
|
$-31.63M |
|
$-31.63M |
|
$-22.87M |
|
$-22.87M |
|
113.63M |
|
113.63M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$93.09M |
|
-- |
|
$33.00M |
|
$126.09M |
|
$11.79M |
|
-- |
|
$42.27M |
|
$54.06M |
|
$33.01M |
|
$72.03M |
|
$72.03M |
|
80.89M |
|
| Cash Flow Statement Financials | |
$-45.29M |
|
$29.19M |
|
$0.09M |
|
$22.81M |
|
$6.80M |
|
$-16.00M |
|
$5.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-45.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-95.81% |
-43.91% |
|
-25.08% |
|
-43.91% |
|
$0.89 |
|
$-0.40 |
|
$-0.40 |
|